A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT)

Low Dosage Computerized Tomography (LDCT) has been shown to improve early detection of lung cancer and mortality rates in high-risk individuals, which was, however, limited by specifically coverage for heavy smokers and high rates of false positivity. Here, we aim to investigate a novel biomarker fo...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncotarget
المؤلفون الرئيسيون: Wang, Xiaobing, Zhi, Xiuyi, Yang, Zhaogang, Tian, Haimei, Li, Yanfen, Li, Mo, Zhao, Wenya, Zhang, Chao, Wang, Teng, Liu, Jing, Shen, Di, Zheng, Cuining, Zhao, Dan, Yang, Sheng, Qi, Jun, Xin, Hongwu, Stojadinovic, Alexander, Avital, Itzhak, Lee, L. James, Rao, Jianyu, Zhang, Wei
التنسيق: Artigo
اللغة:Inglês
منشور في: Impact Journals LLC 2017
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5542191/
https://ncbi.nlm.nih.gov/pubmed/28514755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17477
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة